DENTSPLY SIRONA (NASDAQ:XRAY) Updates FY 2024 Earnings Guidance

DENTSPLY SIRONA (NASDAQ:XRAY) updated its FY 2024 earnings guidance on Wednesday. The company provided earnings per share guidance of 1.960-2.020 for the period, compared to the consensus earnings per share estimate of 2.010. The company issued revenue guidance of $3.9 billion-$3.9 billion, compared to the consensus revenue estimate of $3.9 billion. DENTSPLY SIRONA also updated its FY24 guidance to $1.96 to $2.02 EPS.

Analysts Set New Price Targets

Several brokerages recently issued reports on XRAY. Barrington Research restated an outperform rating and issued a $38.00 target price on shares of DENTSPLY SIRONA in a report on Monday, July 8th. Needham & Company LLC reduced their price target on shares of DENTSPLY SIRONA from $42.00 to $36.00 and set a buy rating on the stock in a report on Friday, May 3rd. Stifel Nicolaus reduced their price target on shares of DENTSPLY SIRONA from $30.00 to $28.00 and set a hold rating on the stock in a report on Thursday, July 18th. Evercore ISI reduced their price target on shares of DENTSPLY SIRONA from $28.00 to $27.00 and set an outperform rating on the stock in a report on Tuesday, July 9th. Finally, Robert W. Baird reduced their price target on shares of DENTSPLY SIRONA from $33.00 to $31.00 and set a neutral rating on the stock in a report on Monday, July 22nd. Five research analysts have rated the stock with a hold rating and seven have issued a buy rating to the company. According to data from MarketBeat.com, the stock has a consensus rating of Moderate Buy and an average target price of $33.67.

DENTSPLY SIRONA Price Performance

Shares of NASDAQ:XRAY traded up $0.51 on Wednesday, reaching $27.29. The company’s stock had a trading volume of 337,546 shares, compared to its average volume of 3,091,503. DENTSPLY SIRONA has a 52-week low of $23.94 and a 52-week high of $41.56. The company has a market cap of $5.67 billion, a P/E ratio of -60.86, a PEG ratio of 1.18 and a beta of 1.01. The company has a 50-day simple moving average of $26.28 and a 200 day simple moving average of $30.27. The company has a debt-to-equity ratio of 0.54, a quick ratio of 0.97 and a current ratio of 1.43.

DENTSPLY SIRONA (NASDAQ:XRAY) last released its quarterly earnings data on Thursday, May 2nd. The medical instruments supplier reported $0.42 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.42. The company had revenue of $953.00 million during the quarter, compared to analysts’ expectations of $969.45 million. DENTSPLY SIRONA had a negative net margin of 2.41% and a positive return on equity of 11.54%. The firm’s quarterly revenue was down 2.6% on a year-over-year basis. During the same period in the previous year, the company earned $0.39 EPS. As a group, equities research analysts anticipate that DENTSPLY SIRONA will post 2.02 EPS for the current fiscal year.

DENTSPLY SIRONA Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Friday, July 12th. Investors of record on Friday, June 28th were given a dividend of $0.16 per share. This represents a $0.64 annualized dividend and a yield of 2.35%. The ex-dividend date of this dividend was Friday, June 28th. DENTSPLY SIRONA’s payout ratio is currently -145.45%.

Insider Buying and Selling

In other news, Director Gregory T. Lucier acquired 3,577 shares of the business’s stock in a transaction that occurred on Friday, May 31st. The stock was purchased at an average cost of $27.95 per share, for a total transaction of $99,977.15. Following the completion of the transaction, the director now owns 58,374 shares in the company, valued at $1,631,553.30. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. 0.52% of the stock is owned by company insiders.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.